Description
Hugh A. D'Andrade (b. 1938): Executive with Schering-Plough Corp., 1981-present; Schering-Plough alliances with Biogen and DNAX Research Institute; commercializing recombinant DNA technology at Biogen and DNAX; biotechnology in New Jersey; comments on BIO (Biotechnology Industry Organization). David P. Holveck (b. 1945): CEO Centocor, 1983-present; work on monoclonal antibody diagnostics and therapeutics, forward integration; partnering with Eli Lilly, corporate, culture; biotechnology in Pennsylvania. Edward E. Penhoet (b. 1940): education, Stanford, Illinois and Washington; biochemistry professor, UC Berkeley, 1970-present; president and CEO, Chiron Corp., 1981-1998; discusses Chiron founders, financing, commercialization of recombinant DNA, staff recruitment, corporate growth, bioentrepreneurs.
Supplemental material: includes research files on Hugh D'Andrade and David Holveck.